Litigation working through the judicial system could restore, or permanently alter, the Title X program. There are three cases to watch. Here’s a quick breakdown of where they stand.
Author: Jessica Grossman
Jessica Grossman, MD, is the chief executive officer of Medicines360, a nonprofit global women’s health pharmaceutical company with a mission to expand access to quality medicines for all women regardless of their socioeconomic status, insurance coverage or geographic location.
What Birth Control Made Possible for Women
It is important to remember that we all stand on the shoulders of the women who came before us and who fought for our reproductive freedoms. But the progress they made is ongoing—and we must continue their fight.